The report provides a detailed analysis essential for establishing an artemether production plant. It encompasses all critical aspects necessary for artemether production, including the cost of artemether production, artemether plant cost, artemether production costs, and the overall artemether production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an artemether production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Artemether is a pharmaceutical compound widely used in the treatment of malaria, particularly infections caused by Plasmodium falciparum. It belongs to the artemisinin class of drugs and is commonly formulated in combination therapies to improve treatment effectiveness and reduce the risk of drug resistance. It is primarily utilised as an active ingredient in antimalarial medications that help eliminate malaria parasites from the bloodstream.
It is mainly used in antimalarial medications, especially in artemether-lumefantrine formulations that are administered for both uncomplicated and severe malaria cases. It is available in oral tablets, capsules, and injectable forms for clinical use. Moreover, it is also utilised in pharmaceutical research and drug development aimed at improving malaria therapies and exploring potential activity against other parasitic diseases.
The market for artemether is primarily driven by its application as an antimalarial drug for the treatment of malaria, which significantly promotes its demand in the medical and pharmaceutical industries. Its utilisation as an antiparasitic medication in the treatment of strains of malaria which are multi-drug resistant largely strengthens its demand in the medical sector. Its application in combination therapies, particularly with other drugs like lumefantrine, to improve treatment effectiveness and reduce the risk of drug resistance further boosts its demand in the pharmaceutical industry. Its usage as an antimalarial agent in injectable and oral pharmaceutical formulations designed for rapid action against malaria infections also contributes to its demand in the pharmaceutical and healthcare industries.
Its involvement in medical research and drug development programs focused on improving malaria treatment and controlling the spread of parasitic diseases also drives its demand in the pharmaceutical production industry. Its demand as an important drug distributed through global health programs and public healthcare systems in regions where malaria is widespread also supports its market growth. Additionally, procurement practices are defined on the basis of several factors, including the cost and availability of raw materials derived from artemisinin sources, regulatory approvals, and quality standards in pharmaceutical production. Technological improvements in drug formulation, supplier reliability, sustainability of raw material sourcing, and efficient supply chain systems significantly influence industrial artemether procurement worldwide.
Raw Material for Artemether Production
According to the artemether production plant project report, the major raw materials for artemether production includes artemisinin.
Production Process of Artemether
The extensive artemether production cost report consists of the following industrial production process:
- Production from Artemisinin: The production process of artemether begins with the reduction of artemisinin in methanol using sodium borohydride, which converts it into dihydroartemisinin. This step is carried out under controlled low-temperature conditions to ensure smooth conversion. Without isolating the intermediate product, the reaction mixture is directly subjected to methylation in the same reaction vessel using an acid catalyst, allowing the formation of artemether through a metherification step. Once the reaction is complete, the mixture undergoes standard processing steps to remove reaction impurities. Then, the crude artemether obtained is purified through silica gel column chromatography to produce purified alpha and beta artemether as the desired product.
Artemether is a semi-synthetic methyl ether derivative of dihydroartemisinin, belonging to the artemisinin class of antimalarial compounds. It appears as a white to off-white crystalline powder and is an optically active molecule containing eight asymmetric centres. The molecular formula of the compound is C16H26O5, and its molar mass is 298.37 g/mol. Its density is 1.18 g/cm³, and it has a melting point in the range of 86–90 degree Celsius. The boiling point of the compound is around 358 degree Celsius. The flash point of artemether is 141 degree Celsius. In terms of solubility, artemether is freely soluble in acetone, soluble in methanol and ethanol, and practically insoluble in water, making it a highly lipophilic compound. It is also soluble in DMSO and DMF. The compound is classified as mildly toxic and flammable, and appropriate precautions should be observed during handling and storage, which should be maintained under cool, dry, and well-ventilated conditions.